81 investors have funded 23 Life Sciences companies head-officed in Utrecht, across 147 rounds (Jan 2006 – Mar 2026). They are ranked by how many Utrecht companies in this market they have actually backed.
"In Utrecht" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | ROM Utrecht Region | Utrecht, Netherlands | SeedSeries BSeries D | 6 | 7 | — | Mar 2026 | 24 |
| 2 | Utrecht Holdings | Utrecht, Netherlands | Series A | 4 | 4 | 1 | Sep 2020 | 7 |
| 3 | Invest-NL | Amsterdam, Netherlands | Series BSeries D | 3 | 5 | 1 | Mar 2026 | 61 |
| 4 | Health Innovations | Utrecht, Netherlands | SeedSeries ASeries B | 3 | 5 | 2 | Sep 2025 | 24 |
| 5 | Curie Capital | Amsterdam, Netherlands | SeedSeries A | 3 | 5 | 2 | Dec 2025 | 8 |
| 6 | Utrecht Holdings Seed Fund | Utrecht, Netherlands | Series ASeed | 3 | 5 | 1 | May 2025 | 7 |
| 7 | European Union | Belgium | Series BSeries A | 3 | 4 | — | Mar 2026 | 195 |
| 8 | Thuja Capital | Utrecht, Netherlands | PESeries A | 3 | 3 | 2 | Oct 2016 | 30 |
| 9 | Life Sciences Partners | Amsterdam, Netherlands | Series BSeries C | 2 | 6 | 1 | Dec 2021 | 105 |
| 10 | Aglaia | Bilthoven, Netherlands | Series BSeries CSeries A | 2 | 5 | — | Aug 2015 | 8 |
| 11 | Oost NL | Apeldoorn, Netherlands | Series BSeries A | 2 | 4 | — | Apr 2025 | 110 |
| 12 | Inkef | Amsterdam, Netherlands | Series BSeries CSeries A | 2 | 4 | 1 | Dec 2025 | 50 |
| 13 | Novartis Venture Fund | Basel, Switzerland | Series BSeries C | 1 | 3 | — | Aug 2015 | 139 |
| 14 | Bay City Capital | San Francisco, United States | Series BSeries C | 1 | 3 | — | Aug 2015 | 60 |
| 15 | Holland Capital | Amsterdam, Netherlands | Series ASeries BSeed | 1 | 3 | 1 | Feb 2022 | 50 |
| 16 | Sonder Capital | San Carlos, United States | Series BSeries A | 1 | 3 | 2 | Mar 2026 | 9 |
| 17 | Johnson & Johnson Innovation – JJDC | New Brunswick, United States | Series BSeries C | 1 | 2 | — | Aug 2015 | 120 |
| 18 | Sunstone | Copenhagen, Denmark | Series A | 1 | 2 | 1 | Dec 2025 | 89 |
| 19 | Pfizer | New York City, United States | Series B | 1 | 2 | — | Oct 2013 | 110 |
| 20 | Kurma Partners | Paris, France | Seed | 1 | 2 | 2 | Mar 2026 | 61 |
| 21 | Pfizer Venture Investments | New York City, United States | Series BSeries C | 1 | 2 | — | Aug 2015 | 58 |
| 22 | Andera Partners | Paris, France | Series A | 1 | 2 | 1 | Dec 2025 | 56 |
| 23 | Innovation Industries | Amsterdam, Netherlands | Series D | 1 | 2 | 1 | Jan 2026 | 39 |
| 24 | BioGeneration Ventures | Naarden, Netherlands | Series A | 1 | 2 | 1 | Dec 2025 | 38 |
| 25 | Nina Capital | Barcelona, Spain | Seed | 1 | 2 | 2 | May 2025 | 36 |
| 26 | Medicxi | London, United Kingdom | Series ASeed | 1 | 2 | — | Mar 2016 | 40 |
| 27 | Hadean Ventures | Oslo, Norway | Series A | 1 | 2 | 1 | Dec 2025 | 20 |
| 28 | NYBC Ventures | Boston, United States | Series B | 1 | 2 | — | Mar 2026 | 11 |
| 29 | Erasmus MC Biomedical Fund | Rotterdam, Netherlands | SeedSeries A | 1 | 2 | — | May 2009 | 5 |
| 30 | Index Ventures | London, United Kingdom | PE | 1 | 1 | 1 | Nov 2014 | 639 |
| 31 | HTGF | Bonn, Germany | Seed | 1 | 1 | 1 | Oct 2013 | 672 |
| 32 | FJ Labs | New York City, United States | Seed | 1 | 1 | 1 | Jun 2019 | 661 |
| 33 | Novo Holdings | Hellerup, Denmark | Series C | 1 | 1 | — | Aug 2015 | 286 |
| 34 | RA Capital Management | Boston, United States | Series C | 1 | 1 | — | Aug 2015 | 317 |
| 35 | Bayern Kapital | Landshut, Germany | Seed | 1 | 1 | 1 | Oct 2013 | 182 |
| 36 | Eurazeo | Paris, France | Seed | 1 | 1 | — | Dec 2025 | 191 |
| 37 | Sofinnova Investments | Menlo Park, United States | Series C | 1 | 1 | — | Aug 2015 | 143 |
| 38 | EQT | Stockholm, Sweden | Series D | 1 | 1 | — | Sep 2025 | 205 |
| 39 | BOM | Tilburg, Netherlands | Series A | 1 | 1 | 1 | May 2020 | 104 |
| 40 | Rock Springs Capital | Baltimore, United States | Series C | 1 | 1 | — | Aug 2015 | 110 |
| 41 | LRM | Hasselt, Belgium | Series A | 1 | 1 | — | Jan 2013 | 63 |
| 42 | LabCorp | Burlington, United States | Series B | 1 | 1 | — | Mar 2026 | 57 |
| 43 | Kreos Capital | London, United Kingdom | Series B | 1 | 1 | — | Jun 2020 | 56 |
| 44 | Mayo Clinic | Rochester, United States | Series B | 1 | 1 | — | Mar 2026 | 55 |
| 45 | Tekla Capital Management | Boston, United States | Series C | 1 | 1 | — | Aug 2015 | 44 |
| 46 | Ampersand Capital | Wellesley, United States | Series B | 1 | 1 | 1 | May 2019 | 40 |
| 47 | Vesalius Biocapital Partners | Strassen, Luxembourg | Series A | 1 | 1 | — | Jan 2013 | 26 |
| 48 | Fund+ | Leuven, Belgium | Series A | 1 | 1 | — | Dec 2025 | 16 |
| 49 | Angelini Ventures | Rome, Italy | Seed | 1 | 1 | — | Dec 2025 | 22 |
| 50 | Icos Capital | Rotterdam, Netherlands | Seed | 1 | 1 | — | Jun 2011 | 23 |
| 51 | Borski Fund | Amsterdam, Netherlands | Series B | 1 | 1 | 1 | Feb 2022 | 17 |
| 52 | Value Creation Capital | Bilthoven, Netherlands | Seed | 1 | 1 | — | May 2025 | 18 |
| 53 | Apollo Health Ventures | Cambridge, United States | Seed | 1 | 1 | 1 | Sep 2022 | 14 |
| 54 | NextGen Ventures | Ede, Netherlands | Series A | 1 | 1 | — | Sep 2020 | 17 |
| 55 | asif | Amsterdam, Netherlands | Seed | 1 | 1 | — | Jan 2022 | 16 |
| 56 | Healthy.Capital | Amsterdam, Netherlands | Seed | 1 | 1 | — | Nov 2025 | 15 |
| 57 | Longevitytech.fund | Boca Raton, United States | Seed | 1 | 1 | — | Sep 2022 | 13 |
| 58 | PGGM | Utrecht, Netherlands | Series B | 1 | 1 | — | Mar 2026 | 13 |
| 59 | Cancer Research Horizons | London, United Kingdom | Seed | 1 | 1 | — | Dec 2025 | 10 |
| 60 | Inkef Capital | Amsterdam, Netherlands | Series B | 1 | 1 | 1 | Jan 2016 | 8 |
| 61 | Baxalta | Chicago, United States | Series A | 1 | 1 | — | Mar 2016 | 4 |
| 62 | Puma Venture Capital | San Diego, United States | Series B | 1 | 1 | — | Mar 2026 | 5 |
| 63 | Sutter Health | Sacramento, United States | Series B | 1 | 1 | — | Mar 2026 | 5 |
| 64 | Venturing Tech | Almelo, Netherlands | Series D | 1 | 1 | — | Jan 2026 | 5 |
| 65 | Partners in Equity | Amsterdam, Netherlands | Series C | 1 | 1 | 1 | Dec 2021 | 4 |
| 66 | TechFund One | Amsterdam, Netherlands | Series A | 1 | 1 | 1 | May 2020 | 4 |
| 67 | Cancer Research UK | Oxford, United Kingdom | Seed | 1 | 1 | — | Dec 2025 | 4 |
| 68 | TechNano Fund | Bilthoven, Netherlands | Series A | 1 | 1 | 1 | Oct 2016 | 4 |
| 69 | Mammoth | Fort Wayne | Seed | 1 | 1 | — | Aug 2021 | 3 |
| 70 | Argobio | Paris, France | Seed | 1 | 1 | — | Dec 2025 | 3 |
| 71 | Health~Holland | The Hague, Netherlands | Seed | 1 | 1 | 1 | Nov 2020 | 2 |
| 72 | Partners in Equity | Series D | 1 | 1 | — | Sep 2025 | 2 | |
| 73 | Rising Star Venture Partners | Seed | 1 | 1 | — | Nov 2025 | 2 | |
| 74 | Benderanalyticalholding | Series B | 1 | 1 | 1 | Apr 2025 | 1 | |
| 75 | Health Innovations | Mount Pleasant, United States | Series C | 1 | 1 | — | Dec 2021 | 1 |
| 76 | Healthinnovation | Netherlands | Series B | 1 | 1 | — | Feb 2022 | 1 |
| 77 | Inspine | Netherlands | Seed | 1 | 1 | — | Jun 2022 | 1 |
| 78 | Oncode Institute | Seed | 1 | 1 | — | Dec 2025 | 1 | |
| 79 | Intervest | Series B | 1 | 1 | — | Mar 2026 | 1 | |
| 80 | Biovance Capital | Seed | 1 | 1 | 1 | Mar 2026 | 1 | |
| 81 | McPike Global Family Office | Series B | 1 | 1 | — | Mar 2026 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Utrecht that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Kaleido hellokaleido.com |
13 | 19 | $816.5M | Series D Jan 2026 |
| Merus merus.nl |
12 | 24 | $1.4B | Series C Aug 2015 |
| Vitestro vitestro.com |
12 | 17 | $940.9M | Series B Mar 2026 |
| TargED targedbiopharmaceuticals.com |
10 | 18 | $502.8M | Series A Dec 2025 |
| Laigo Biotechnology laigobio.com |
10 | 11 | $133.3M | Seed Mar 2026 |
| AMT Medical amt-medical.nl |
6 | 7 | $135.2M | Series B Apr 2025 |
| Prolira prolira.com |
6 | 10 | $28.6M | Series B Feb 2022 |
| Cleara clearabiotech.com |
5 | 5 | $10M | Seed Sep 2022 |
| CryoCloud cryocloud.io |
4 | 7 | $10.7M | Seed May 2025 |
| Gadeta gadeta.nl |
3 | 4 | $23.5M | Series A Mar 2016 |
| Core Life Analytics corelifeanalytics.com |
3 | 3 | $3.3M | Series A May 2020 |
| Cavadis cavadis.com |
3 | 4 | — | Series A May 2009 |
| Encare Biotech encarebiotech.com |
2 | 2 | $13.7M | PE Nov 2014 |
| FF Pharma ffpharma.com |
2 | 2 | $10.6M | Series A Jan 2013 |
| MRIguidance mriguidance.com |
2 | 2 | $3M | Seed Aug 2021 |
| Guideways guideways.ai |
2 | 2 | $2.3M | Seed Nov 2025 |
| MILabs milabs.com |
2 | 2 | — | Series A Oct 2016 |
| Cresco cresco-spine.com |
2 | 2 | — | Seed Jun 2022 |
| Photonics Healthcare photonicshealthcare.com |
2 | 2 | — | Seed Oct 2013 |
| Ascenscia ascenscia.ai |
1 | 1 | $28.4K | Seed Jan 2022 |
| Somantix somantix.com |
1 | 1 | — | Seed Jun 2008 |
| MicroDish microdish.nl |
1 | 1 | — | Seed Jun 2011 |
| GenDx gendx.com |
1 | 1 | — | Series B May 2019 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Mar 2026 | Kurma PartnersLED | Laigo Biotechnology | Seed | $6.4M |
| Mar 2026 | Biovance CapitalLED | Laigo Biotechnology | Seed | $6.4M |
| Mar 2026 | Puma Venture Capital | Vitestro | Series B | $70M |
| Mar 2026 | Europa | Vitestro | Series B | $70M |
| Mar 2026 | Mayo Clinic | Vitestro | Series B | $70M |
| Mar 2026 | LabCorp | Vitestro | Series B | $70M |
| Mar 2026 | PGGM | Vitestro | Series B | $70M |
| Mar 2026 | Sutter Health | Vitestro | Series B | $70M |
| Mar 2026 | Sonder Capital | Vitestro | Series B | $70M |
| Mar 2026 | Intervest | Vitestro | Series B | $70M |
| Mar 2026 | Invest-NL | Vitestro | Series B | $70M |
| Mar 2026 | ROM Utrecht Region | Vitestro | Series B | $70M |
| Mar 2026 | NYBC Ventures | Vitestro | Series B | $70M |
| Mar 2026 | McPike Global Family Office | Vitestro | Series B | $70M |
| Jan 2026 | Innovation Industries | Kaleido | Series D | $13M |
| Jan 2026 | ROM Utrecht Region | Kaleido | Series D | $13M |
| Jan 2026 | Venturing Tech | Kaleido | Series D | $13M |
| Dec 2025 | Hadean Ventures | TargED | Series A | $25.2M |
| Dec 2025 | Fund+ | TargED | Series A | $25.2M |
| Dec 2025 | Sunstone | TargED | Series A | $25.2M |
Life Sciences investors in other cities
Other markets in Utrecht